Camurus AB (OSTO:CAMX) Change In Receivables : kr-222 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Change In Receivables?

Camurus AB's change in receivables for the quarter that ended in Dec. 2024 was kr-116 Mil. It means Camurus AB's Accounts Receivable increased by kr116 Mil from Sep. 2024 to Dec. 2024 .

Camurus AB's change in receivables for the fiscal year that ended in Dec. 2024 was kr-222 Mil. It means Camurus AB's Accounts Receivable increased by kr222 Mil from Dec. 2023 to Dec. 2024 .

Camurus AB's Accounts Receivable for the quarter that ended in Dec. 2024 was kr416 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Camurus AB's Days Sales Outstanding for the three months ended in Dec. 2024 was 68.68.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Camurus AB's liquidation value for the three months ended in Dec. 2024 was kr2,768 Mil.

Camurus AB Change In Receivables Historical Data

The historical data trend for Camurus AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Change In Receivables Chart

Camurus AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-20.06

-92.61

-77.70

-88.49

-221.91

Camurus AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-25.83	-55.99	-91.51	41.98	-116.39

Camurus AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-222 Mil.

Camurus AB (OSTO:CAMX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Camurus AB's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	416.344	/	553.131	*	91
=	68.68

2. In Ben Graham's calculation of liquidation value, Camurus AB's accounts receivable are only considered to be worth 75% of book value:

Camurus AB's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2852.699	-	467.331	+	0.75 * 416.344	+	0.5 * 140.223
=	2,768

Camurus AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Camurus AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OSTO:CAMX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CAMRF:USA CAMXs:UK 0RD1:UK 7CA:Germany

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.